Abbreviations: AION, anterior ischemic optic neuropathy; BRAO ... The authors declared no competing interests. The types of posterior segment clinical signs relating to the various vasculitides ...
A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...
Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...
Letters to the Editor Polymyalgia Rheumatica Sex-Specific Epidemiology, Diagnostic and Therapeutic Approach, and Medical Care by Miriam Giovanna Colombo, MPH; Anna-Jasmin Wetzel, M.Sc.; Dr. med.
HealthDay on MSN21d
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic NeuropathyUse of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy in those with type 2 diabetes.
The posterior segment of the eye has two ... Other eye involved in 15% of cases at 5 years Abbreviations: AION, anterior ischemic optic neuropathy; BRAO, branch retinal artery occlusion; CWS ...
Get Instant Summarized Text (Gist) Once-weekly semaglutide use in individuals with type 2 diabetes more than doubles the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION ...
Findings seen for patients with type 2 diabetes during a 5-year period. (HealthDay News) — Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results